Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Community Healthcare Trust Incorporated (CHCT) has a Wall Street consensus price target of $18.50, based on estimates from 16 covering analysts. With the stock currently trading at $17.09, this represents a potential upside of +8.3%. The company has a market capitalization of $487M.
Analyst price targets range from a low of $17.00 to a high of $20.00, representing a 16% spread in expectations. The median target of $18.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 7 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, CHCT trades at a trailing P/E of 220.8x and forward P/E of 36.4x. Analysts expect EPS to grow +147.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $17.09, with bear and bull scenarios of $12.83 and $67.58 respectively. Model confidence stands at 52/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how CHCT stacks up against sector leader Welltower Inc..
Start ComparisonThe consensus price target for CHCT is $18.5, close to the current price of $17.09 (8.3% implied move). Based on 16 analyst estimates, the stock appears fairly valued near current levels.
CHCT has a consensus rating of "Hold" based on 16 Wall Street analysts. The rating breakdown is mixed, with 8 Hold ratings making up the largest segment. The consensus 12-month price target of $18.5 implies 8.3% upside from current levels.
At a forward P/E of 36.3617x, CHCT trades at a premium valuation. The consensus price target of $18.5 (8.3% upside) suggests analysts may view current valuations as stretched.
The most bullish Wall Street analyst has a price target of $20 for CHCT, while the most conservative target is $17. The consensus of $18.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $68 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CHCT is well covered by analysts, with 16 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 8 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CHCT stock forecast based on 16 Wall Street analysts shows a consensus price target of $18.5, with estimates ranging from $17 (bear case) to $20 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $17, with bear/bull scenarios of $13/$68.
Our quantitative valuation model calculates CHCT's fair value at $17 (base case), with a bear case of $13 and bull case of $68. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 52/100.
CHCT trades at a forward P/E ratio of 36.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 220.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
CHCT appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $18.5 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CHCT analyst price targets range from $17 to $20, a 16% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $18.5 consensus represents the middle ground. Our model's $13-$68 range provides an independent fundamental perspective.